Literature DB >> 534065

Treatment of increased intracranial pressure: a comparison of different hyperosmotic agents and the use of thiopental.

A B Levin, T A Duff, M J Javid.   

Abstract

Long term intracranial pressure (ICP) monitoring was carried out in over 200 patients with various intracranial abnormalities; a fiberoptic epidural intracranial pressure monitor was used. Ninety of these patients had significantly elevated ICP or exhibited pressure waves requiring therapy. Initial therapy consisted of hyperventilation with a respirator and administration of hyperosmotic agents. Comparison studies utilizing 30% urea, 20% mannitol, and furosemide intravenously and 30% urea and 10% glycerol orally were randomly done. In 45 patients two or more of these agents were used at different times in the same patient for comparison of effectiveness. When equimolar amounts of intravenous urea and mannitol were used, similar effects on increased ICP were obtained. There was no significant reduction of increased ICP with the use of furosemide alone. No rebound effect was observed with either mannitol or urea. Orally, urea was more effective than glycerol in equimolar amounts. Again no rebound was observed. In 14 patients who required doses of hyperosmotic agents more frequently than every 4 hours, continuous infusion of thiopental was used in conjunction with the hyperosmotic agents to control pressure. This regimen resulted in good ICP control in 12 patients. A rational protocol for the medical management of increased ICP utilizing hyperosmotic agents and, in refractory cases, hyperosmotic agents plus thiopental has resulted in effective control of ICP in 96% of our patients throughout their course without the need to resort to decompressive surgery. (Neurosurgery, 5: 570--575, 1979).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 534065     DOI: 10.1227/00006123-197911000-00005

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

Review 1.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

Review 2.  Mannitol for acute traumatic brain injury.

Authors:  Abel Wakai; Aileen McCabe; Ian Roberts; Gillian Schierhout
Journal:  Cochrane Database Syst Rev       Date:  2013-08-05

Review 3.  Pharmacologic Neuroprotection for Functional Outcomes After Traumatic Brain Injury: A Systematic Review of the Clinical Literature.

Authors:  Shaun E Gruenbaum; Alexander Zlotnik; Benjamin F Gruenbaum; Denise Hersey; Federico Bilotta
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

4.  Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture.

Authors:  Lucy Vulchanova; Daniel J Schuster; Lalitha R Belur; Maureen S Riedl; Kelly M Podetz-Pedersen; Kelley F Kitto; George L Wilcox; R Scott McIvor; Carolyn A Fairbanks
Journal:  Mol Pain       Date:  2010-05-28       Impact factor: 3.395

Review 5.  Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors.

Authors:  Jessica I Griffith; Sneha Rathi; Wenqiu Zhang; Wenjuan Zhang; Lester R Drewes; Jann N Sarkaria; William F Elmquist
Journal:  Pharmaceutics       Date:  2020-12-11       Impact factor: 6.321

6.  Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.

Authors:  Aaron M Cook; G Morgan Jones; Gregory W J Hawryluk; Patrick Mailloux; Diane McLaughlin; Alexander Papangelou; Sophie Samuel; Sheri Tokumaru; Chitra Venkatasubramanian; Christopher Zacko; Lara L Zimmermann; Karen Hirsch; Lori Shutter
Journal:  Neurocrit Care       Date:  2020-06       Impact factor: 3.210

7.  Clinical translation of hyperpolarized 13 C pyruvate and urea MRI for simultaneous metabolic and perfusion imaging.

Authors:  Hecong Qin; Shuyu Tang; Andrew M Riselli; Robert A Bok; Romelyn Delos Santos; Mark van Criekinge; Jeremy W Gordon; Rahul Aggarwal; Rui Chen; Gregory Goddard; Chunxin Tracy Zhang; Albert Chen; Galen Reed; Daniel M Ruscitto; James Slater; Renuka Sriram; Peder E Z Larson; Daniel B Vigneron; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2021-08-10       Impact factor: 3.737

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.